Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

FY23 trading update

4 Apr 2023 07:00

RNS Number : 2186V
FD Technologies PLC
04 April 2023
 

 

 

4 April 2023

FD Technologies plc

("FD Technologies" or the "Group")

 

FY23 trading update

 

FD Technologies (AIM: FDP.L, Euronext Growth: FDP.I) announces a trading update for the year ended 28 February 2023 ahead of full year results expected to be announced on 23 May 2023.

 

Our progress was led by KX and First Derivative. As the engine for real-time analytics in the cloud, KX continues to experience significant, growing momentum. We are excited by the opportunities arising from its market position, enabled by the investments made in product and go-to-market.

 

Seamus Keating, Group CEO, said: "KX and First Derivative have performed strongly, with both revenue and EBITDA ahead of our expectations, as each business strengthened its market position.

 

KX in particular has made strong commercial and strategic progress, driven by our market-leading ability to deliver 100x the performance at one tenth of the cost of alternative solutions. These advantages are particularly compelling for hyperscale cloud providers, resulting in a range of initiatives which we are progressing with our partners that provide further confidence in our outlook.

 

First Derivative also performed strongly and continued to deliver impressive revenue growth of 18% for the period. We continue to see multi-year strategic growth drivers that will underpin demand for our services.

 

We have set ourselves ambitious but sustainable growth targets for the years ahead which will ensure we are focused on driving high-quality recurring revenue growth from an expanding list of customers across a wide range of industries, while generating long term value for shareholders."

 

Highlights

 

·

Group revenue is expected to be approximately £296m, representing growth of 12%, despite the strengthening of the dollar against sterling in H2.

·

Group EBITDA is expected to be approximately £35m, with strong performances at KX and First Derivative offset by a weak demand environment at MRP.

·

Strong cash management in H2 resulted in a net cash position at the year end of £0.4m, compared to net debt of £7.4m at end August 2022.

·

KX delivered a strong performance, ahead of guidance, with revenue of approximately £80m and ARR* of £65m, a 39% increase on the prior year.

·

Recent KX successes include the general availability of kdb Insights Enterprise on Microsoft Azure, the industry's first Data Timehouse, together with new customer wins including Syneos Health and PSE, the Polish national electricity transmission system operator.

·

First Derivative delivered revenue of approximately £174m, representing growth of 18%, ahead of our guidance for the year; MRP revenue was approximately £41m, a decline of 19%, primarily due to macro-economic conditions.

 

Business unit performance

 

KX made significant strategic progress during the year, meeting or beating every key performance indicator, and increasing our confidence in its sustainable growth prospects. Over the last year, incremental annual contract value (ACV)** almost doubled to £19m and ARR grew by 39%, highlighting our sales success during the period. We broadened and deepened our strategic partner base, added significant new customers across our target markets, continued to make kdb easier to adopt and use - driving improved time-to-value to attract new customers - and made significant enhancements to our go-to-market strategy.

 

Throughout the year, we have seen an increasing proportion of new bookings from our initiatives with our partners, particularly the hyperscale cloud vendors. We also recently announced the general availability of kdb Insights Enterprise on Microsoft Azure, a watershed moment in our strategic partnership with Microsoft, as we work to enable companies in all sectors to access the power of kdb for enhanced operational and commercial outcomes.

 

First Derivative had another strong year with both revenue and EBITDA ahead of our expectations. We believe that the business is well-positioned to deliver sustainable double-digit revenue growth and margin improvement.

 

MRP, which represents 14% of our revenue, continued to experience a weaker demand environment through the year. We took further action to align the cost base during H2, which will benefit the current year.

 

Outlook

 

Our mission in KX is to accelerate the speed of data and AI-driven business innovation across all enterprises through real-time analytics, with kdb as the engine that enables the processing and analysis of time series and machine data for smarter decision making wherever that is a critical business requirement.

 

To deliver this goal we are engaged in multiple discussions with existing and potential new partners and customers on commercial opportunities. The breadth of these discussions and our confidence in our prospects underpins our FY24 guidance for KX to achieve ARR growth of at least 35%.

 

First Derivative continues to perform well, with revenue growth in excess of 10% expected combined with a meaningful improvement towards our three-year target of a 15% EBITDA margin. At MRP we expect the lower cost base to deliver an improvement in EBITDA for the year.

 

*ARR is the value at the period end of recurring software revenue to be recognised in the next twelve months, formerly defined as 'exit annual recurring revenue'

**ACV is the sum of customer contracts signed during the period divided by the number of years in the contract

 

 

Enquiries

For further information please contact:

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.fdtechnologies.com

 

Investec Bank plc (Nominated Adviser and Broker)

Carlton Nelson

Virginia Bull

+44 (0) 20 7597 5970

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 1 667 0420

J.P. Morgan Cazenove (Broker)

James A. Kelly

Mose Adigun

+44 (0) 203 493 8000

 

 

FTI Consulting LLP (Financial PR)

Dwight Burden

Victoria Caton

+44 (0) 20 3727 1000

FDtechnologies@fticonsulting.com

 

 

About FD Technologies

FD Technologies is a group of data-driven businesses that unlock the value of insight, hindsight and foresight to drive organisations forward. The Group comprises KX, the leading technology for real-time continuous intelligence; First Derivative, which provides technology-led services in capital markets; and MRP, the only enterprise-class, predictive Accounts Based Marketing solution. FD Technologies operates from 14 locations across Europe, North America and Asia Pacific, and employs more than 3,100 people worldwide.

 

For further information, please visit www.fdtechnologies.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUMGCUPWGQW
Date   Source Headline
7th Mar 20167:00 amRNSEnterprise Securities Market Notice
1st Mar 20164:14 pmRNSIssue of Equity
29th Jan 20169:46 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSEnterprise Securities Market Notice
22nd Jan 20163:31 pmRNSDirector/PDMR Shareholding
19th Jan 20163:28 pmRNSIssue of Equity
19th Jan 201611:16 amRNSDirector's Shareholding
19th Jan 201610:39 amRNSHolding(s) in Company
15th Jan 20167:00 amRNSEnterprise Securities Market Notice
14th Jan 20167:00 amRNSMOU with Utilismart
13th Jan 20163:25 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSFD acquires QuantumKDB
31st Dec 20157:00 amRNSTotal Voting Rights
7th Dec 20157:00 amRNSEnterprise Securities Market Notice
3rd Dec 20155:00 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSIssue of Equity from exercise of Share Options
11th Nov 20157:00 amRNSHalf Yearly Report
2nd Nov 20157:00 amRNSContract win with National Stock Exchange of India
19th Oct 20157:00 amRNSNotice of Results and Trading Update
30th Sep 20151:33 pmRNSTotal Voting Rights
23rd Sep 20154:46 pmRNSIssue of Equity
16th Sep 20153:07 pmRNSHolding(s) in Company
10th Sep 20157:00 amRNSFormation of FD Labs
28th Aug 20157:00 amRNSTotal Voting Rights
6th Aug 20157:00 amRNSEnterprise Securities Market Notice
3rd Aug 20157:00 amRNSAppointment of Non-Executive Director
31st Jul 201511:22 amRNSIssue of Equity
31st Jul 201511:19 amRNSTotal Voting Rights
21st Jul 20153:22 pmRNSDirector/PDMR Shareholding
7th Jul 20155:31 pmRNSIssue of Equity from exercise of Share Options
25th Jun 20152:02 pmRNSResult of AGM
12th Jun 20155:15 pmRNSDirector's Shareholding
2nd Jun 20157:00 amRNSPreliminary Results
29th May 20154:59 pmRNSTotal Voting Rights
11th May 20157:00 amRNSChange of Adviser and Notice of Results
8th Apr 20157:00 amRNSEnterprise Securities Market Notice
1st Apr 201511:09 amRNSTotal Voting Rights
1st Apr 20157:00 amRNSFD acquires Affinity Systems for up to GBP7.7m
27th Mar 20157:00 amRNSEnterprise Securities Market Notice
24th Mar 20157:01 amRNSDirectorate Change and Appointment
24th Mar 20157:00 amRNSFD acquires ActivateClients Limited
19th Mar 20157:00 amRNSEnterprise Securities Market Notice
13th Mar 20154:29 pmRNSIssue of Equity
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
3rd Mar 20152:00 pmRNSFirst Derivatives strengthens board of Directors
3rd Mar 201511:06 amRNSResult of General Meeting
27th Feb 201511:27 amRNSTotal Voting Rights
26th Feb 20157:01 amRNSFD acquires Prelytix for up to USD20million
23rd Feb 20157:00 amRNSEnterprise Securities Market Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.